Additionally, iNOS inhibitors have been extensively studied for their roles in various conditions, such as multiple sclerosis, inflammatory bowel diseases, Alzheimer’s disease, and rheumatoid arthritis [32]. Here, NOS2 is linked to early-onset autosomal dominant Alzheimer disease.